Stockreport

Silence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Days

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF LONDON--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transfo [Read more]